India.Com Health |
Rheumatoid Arthritis: Your guide to living with the disease
India.Com Health Biologics is the latest and most effective treatment available and it helps in normalising the life of a patient to a great extent. Some of the most common biologic medicines used today are Abatacept, Rituximab and Tocilizumab.’ According to some … |
|
GSK and Genmab file Arzerra for first-line use in US
PMLiVE … not responded to Genzyme’s Campath (alemtuzumab) or the chemotherapy fludarabine, but has brought in relatively modest sales in that setting thanks to robust competition from Roche’s Rituxan/ MabThera (rituximab), which has the same molecular target. |
CELL THERAPEUTICS INC : Cell Therapeutics Announces Results from …4-traders (press release)CTI is currently accruing patients into a Phase 3 trial comparing PIXUVRI and rituximab with gemcitabine and rituximab in the setting of aggressive B-cell NHL….
Proactive Investors USA & Canada |
Cellmid awarded Japanese patent for autoimmune disorder treatment with …
Proactive Investors USA & Canada This adds to its patent coverage and follows its receiving earlier this month of a European patent for the use of anti-midkine antibodies to prevent and treat cancer, inflammatory and autoimmune diseases. The European patent is the most important … |
The Express Tribune (blog) |
My visit to Aga Khan Hospital’s cancer ward
The Express Tribune (blog) Rituximab (rituxan) helps the immune system to attack the cancer cells and Avastin is a monoclonal antibody that can treat a number of cancers except breast cancer. It intercepts the tumour signals and stops them from connecting their targets. Many … |
UT MD Anderson Cancer Moon Shots Take Flight During Year 1HispanicBusiness.comChronic Lymphocytic Leukemia Moon Shot will soon open a 200-patient clinical trial to test the promising experimental drug ibrutinib with or without the existing antibody rit…
|
Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults with …
Sacramento Bee Formal drug interaction studies have not been performed with rituximab or natalizumab; however, because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of CIMZIA … |
|
Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults with …
PR Newswire (press release) Formal drug interaction studies have not been performed with rituximab or natalizumab; however, because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of CIMZIA … |
Fusion Antibodies CDRx Antibody Humanization Platform Generates Novel …DigitalJournal.comFusion Antibodies Ltd have today announced a collaboration with UK medical diagnostics company Isca Diagnostics Ltd for development of their Aspergillus-specific…
Fusion Antibodies CDRx Antibody Humanization Platform Generates Novel …PR Web (press release)Fusion Antibodies CDRx platform has rapidly developed high quality humanized antibodies for Exeter based company Isca Diagnostics. The EU funded project will…